NuVasive (NUVA) is increasing investment in support of adult and pediatric spinal deformity research and education. Initiatives include the MAGEC Matters podcast, focused on early onset scoliosis treatment, as well as research funding for study groups including Harms, Children’s Spine Study Group and the Growing Spine Study Group.
Since 4Q16, company leadership has affirmed its build-up of a pediatric-specific salesforce; its RELINE® Small Stature posterior fixation system is slated for launch this summer. Further, NUVA has launched its own pediatric spinal deformity-centric program, “Embracing the Journey Together,” addressing research, education and event support.
Our observations on the volume of products launched since 4Q16 alone in the pediatric orthopaedic space, and the commentary of experts in the field, suggest that this niche is drawing companies in.
NuVasive (NUVA) is increasing investment in support of adult and pediatric spinal deformity research and education. Initiatives include the MAGEC Matters podcast, focused on early onset scoliosis treatment, as well as research funding for study groups including Harms, Children's Spine Study Group and the Growing Spine Study Group.
Since 4Q16,...
NuVasive (NUVA) is increasing investment in support of adult and pediatric spinal deformity research and education. Initiatives include the MAGEC Matters podcast, focused on early onset scoliosis treatment, as well as research funding for study groups including Harms, Children’s Spine Study Group and the Growing Spine Study Group.
Since 4Q16, company leadership has affirmed its build-up of a pediatric-specific salesforce; its RELINE® Small Stature posterior fixation system is slated for launch this summer. Further, NUVA has launched its own pediatric spinal deformity-centric program, “Embracing the Journey Together,” addressing research, education and event support.
Our observations on the volume of products launched since 4Q16 alone in the pediatric orthopaedic space, and the commentary of experts in the field, suggest that this niche is drawing companies in.
Copy to clipboard 
